Unlocking Innovation: Embracing the Positive Impact of IPR Expiration in India [with special reference to the pharmaceutical industry]
Intellectual Property Rights (IPR) expiration in the Indian context holds the promise of fostering innovation, accessibility, and affordability within the pharmaceutical and technology sectors. This research article provides an overview of the positive impact resulting from the expiration of IPR in India, emphasizing the dynamic transformations that unfold in the realms of healthcare, technology, and economic development.In the pharmaceutical sector, the expiration of patents enables the emergence of generic alternatives, leading to increased competition and a subsequent reduction in the cost of essential medications. This positively influences healthcare accessibility, particularly for economically disadvantaged populations, and encourages domestic pharmaceutical companies to innovate and diversify their product offerings. The role of regulatory frameworks in facilitating this positive transformation is also discussed, emphasizing the need for a balanced approach that safeguards intellectual property rights while encouraging fair competition and widespread innovation. As India positions itself as a hub for innovation and technology, the positive impacts of IPR expiration are expected to reverberate globally, influencing policy discussions and encouraging a more inclusive approach to intellectual property rights. This research article uses the way of primary data collection method through circulating a questionnaire among the people of Bhopal. In conclusion, this research article advocates for a perspective shift towards recognizing IPR expiration as a driver of positive change in India. By unlocking innovation, fostering competition, and enhancing accessibility, India's approach to IPR expiration stands as a model for other nations seeking to strike a balance between protecting intellectual property and promoting socio-economic development
Authors
- Ms. Satvika Dhote
- Mr. Vineet Ringe
Publication Details
- Published
- 2025-07-01
- DOI
- https://doi.org/10.51767/c250614
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00